|1.74||-0.05 / -2.79%|
Data as of 4:00pm ET
|1.74||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +129.89% increase from the last price of 1.74.
The current consensus among 5 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.